CONVENIOS
Agreement
PREIMPLANTATION FACTOR (sPIF): UNA NUEVA TERAPIA PARA EL TRATAMIENTO DE LA HIPERGLUCAGONEMIA EN LA DIABETES MELLITUS
date_range
Duration: from 03 June 2021 to 02 June 2022
(12 months)
Finished
euro
19,998.00 EUR
Of National scope.
In collaboration with other entities.
Researchers
BEATRIZ
MERINO ANTOLIN
Leader